SAD Study of CGB3002 in Healthy Participants

Clinical trial NCT07660341 · RECRUITING

Trial details

NCT number: NCT07660341
Sponsor: ChainGen Biopharma Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer s Disease

Start date: 2026-06-30
Primary completion: 2027-04-30
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.